MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
P/E
--
Forward P/E
370.37
Price/Sales
13.45
Beta
0.544
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Maravai LifeSciences' third quarter 2026 revenue of $45.9M beat estimates as mRNA sales surged 28%
Maravai LifeSciences reported third quarter 2026 revenue of $45.9 million, exceeding analyst estimates of $43.56 million. The company narrowed its adjusted net...
Maravai Lifesciences Holdings Inc Q3 2026 Earnings Preview: What Analysts Expect on November 04, 2026
Maravai Lifesciences is expected to report Q3 2026 revenue of $43.56 million and an adjusted EPS of -$0.07, with the current $7.57 share price trading...